Literature DB >> 819938

Radioimmunoassay of procollagen in serum of patients with Paget's disease of bone.

M B Taubman, S Kammerman, B Goldberg.   

Abstract

A new radioimmunoassay for human procollagen showed that the sera of 46 of 50 untreated patients with Paget's disease of bone contained increased concentrations of procollagen protein as compared to normal adults. After therapy with disodium etidronate, all the elevated serum procollagen concentrations decreased significantly, falling to normal levels in 33 of 40 patients. The procollagen levels before and after treatment were coordinate with the values for urinary total hydroxyproline and serum alkaline phosphatase activity. The data show that the radioimmunoassay for procollagen is a dependable and useful adjunct to the study of Paget's disease of bone.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 819938     DOI: 10.3181/00379727-152-39380

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  5 in total

1.  Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance.

Authors:  J M Kirk; E D Bateman; P L Haslam; G J Laurent; M Turner-Warwick
Journal:  Thorax       Date:  1984-10       Impact factor: 9.139

2.  Collagen metabolism in the liver. An annotated and supplemented report of a workshop at the National Institutes of Health on February 28 and March 1, 1977.

Authors: 
Journal:  Am J Dig Dis       Date:  1978-07

3.  Procollagen-III peptide serum levels in Paget's disease of the bone.

Authors:  C H Wilder-Smith; F Raue; G Holz-Gottswinter; R Ziegler
Journal:  Klin Wochenschr       Date:  1987-02-16

4.  Immunoglobulin abnormalities in Paget's disease of bone.

Authors:  J N Buxbaum; S Kammerman
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

5.  Assessment of bone formation by biochemical markers in metabolic bone disease: separation between osteoblastic activity at the cell and tissue level.

Authors:  P Charles; C Hasling; L Risteli; J Risteli; L Mosekilde; E F Eriksen
Journal:  Calcif Tissue Int       Date:  1992-12       Impact factor: 4.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.